Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Work In Process (2016 - 2018)

Lifecore Biomedical, Inc. \De\ (LFCR) has 7 years of Work In Process data on record, last reported at $3.1 million in Q4 2018.

  • For Q4 2018, Work In Process fell 34.24% year-over-year to $3.1 million; the TTM value through Nov 2018 reached $3.1 million, down 34.24%, while the annual FY2018 figure was $3.7 million, 6.53% up from the prior year.
  • Work In Process reached $3.1 million in Q4 2018 per LFCR's latest filing, down from $3.1 million in the prior quarter.
  • Across five years, Work In Process topped out at $13.0 million in Q4 2016 and bottomed at $1.9 million in Q2 2015.
  • Average Work In Process over 5 years is $3.8 million, with a median of $3.3 million recorded in 2014.
  • Peak YoY movement for Work In Process: skyrocketed 265.69% in 2016, then plummeted 63.95% in 2017.
  • A 5-year view of Work In Process shows it stood at $4.0 million in 2014, then decreased by 11.86% to $3.6 million in 2015, then surged by 265.69% to $13.0 million in 2016, then tumbled by 63.95% to $4.7 million in 2017, then plummeted by 34.24% to $3.1 million in 2018.
  • Per Business Quant database, its latest 3 readings for Work In Process were $3.1 million in Q4 2018, $3.1 million in Q3 2018, and $3.7 million in Q2 2018.